Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Applied Therapeutics Inc banner

Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 0.103 USD 3% Market Closed
Market Cap: $14.9m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 0.255 USD with a low forecast of 0.253 USD and a high forecast of 0.263 USD.

APLT Lowest Forecast
Wall Street Target
0.253 USD
145% Upside
APLT Average Forecast
Wall Street Target
0.255 USD
148% Upside
APLT Highest Forecast
Wall Street Target
0.263 USD
155% Upside
Lowest
Price Target
0.253 USD
145% Upside
Average
Price Target
0.255 USD
148% Upside
Highest
Price Target
0.263 USD
155% Upside
Applied Therapeutics Inc Competitors:
Price Targets
VINP
Vinci Partners Investments Ltd
17% Upside
CYBR
Cyberark Software Ltd
27% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
28% Upside
TELA
TELA Bio Inc
334% Upside
VINP
Vinci Partners Investments Ltd
17% Upside
CYBR
Cyberark Software Ltd
27% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
28% Upside
TELA
TELA Bio Inc
334% Upside
TCPC
BlackRock TCP Capital Corp
36% Upside

Revenue
Forecast

N/A
Past Growth
248% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
248% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 4 years is 248%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss

What are analyst estimates?

See Also

Summary
APLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
APLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APLT stock valuation using valuation multiples.
Wall Street Estimates
APLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APLT's stock price target?
Price Target
0.255 USD

According to Wall Street analysts, the average 1-year price target for APLT is 0.255 USD with a low forecast of 0.253 USD and a high forecast of 0.263 USD.

What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
248%

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 4 years is 248%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.